ANTIAMYLOIDOGENIC EFFECT OF MiR-101 IN EXPERIMENTAL ALZHEIMER’S DISEASE

ANTIAMYLOIDOGENIC EFFECT OF MiR-101 IN EXPERIMENTAL ALZHEIMER’S DISEASE

The aim of the study was to determine the effect of miR-101 on the level of β-amyloid peptide and activation of the cytokine system in the brain regions of animals with an experimental model of Alzheimer’s disease. MiR-101 is the key deactivating operator of mRNA function for the amyloid-β protein p...

Full description

Bibliographic Details
Main Authors:	V. Sokolik, O. Berchenko, N. Levicheva, S. Shulga
Format:	Article
Language:	English
Published:	National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry 2019-06-01
Series:	Biotechnologia Acta
Subjects:	miR-101 β-amyloid peptide amyloidosis Alzheimer’s disease.
Online Access:	http://biotechnology.kiev.ua/images/storage/3_2019/sokolik_3_2019.pdf

Similar Items

Modulating effect of liposomal miR-101 on the processes of amyloidogenesis, smell, sleep and neuroinflammation in experimental Alzheimer's disease
by: V. Sokolik, et al.
Published: (2021-08-01)

The cumulative effect of the combined action of miR-101 and curcumin in a liposome on a model of Alzheimer’s disease in mononuclear cells
by: Victoria Vasilevna Sokolik, et al.
Published: (2023-04-01)

A lentiviral sponge for miR-101 regulates RanBP9 expression and amyloid precursor protein metabolism in hippocampal neurons
by: Christian eBarbato, et al.
Published: (2014-02-01)

MiR-101: An Important Regulator of Gene Expression and Tumor Ecosystem
by: Ning Liu, et al.
Published: (2022-11-01)

MiR‐101 inhibits ovarian carcinogenesis by repressing the expression of brain‐derived neurotrophic factor
by: Ying Xu, et al.
Published: (2017-09-01)

TYMSOS-miR-101-3p-NETO2 axis promotes osteosarcoma progression
by: Zun Zhang, et al.
Published: (2023-02-01)

Schisandrin B suppresses liver fibrosis in rats by targeting miR-101-5p through the TGF-β signaling pathway
by: Wang Cuiqiong, et al.
Published: (2020-01-01)

An in silico approach to identify potential downstream targets of miR-153 involved in Alzheimer’s disease
by: Sanila Amber, et al.
Published: (2024-01-01)

Combined Treatment of Bronchial Epithelial Calu-3 Cells with Peptide Nucleic Acids Targeting miR-145-5p and miR-101-3p: Synergistic Enhancement of the Expression of the Cystic Fibrosis Transmembrane Conductance Regulator (<i>CFTR)</i> Gene
by: Chiara Papi, et al.
Published: (2022-08-01)

NEAT1 promotes the malignant development of bladder cancer by regulating the miR-101/VEGF-C pathway in vitro and in vivo
by: Huihui Zhang, et al.
Published: (2022-11-01)

The effect of miR-101 on the memory of rats with a model of Alzheimer’s disease
by: O. G. Berchenko, et al.
Published: (2020-08-01)

miR-101b Regulates Lipid Deposition and Metabolism of Primary Hepatocytes in Teleost Yellow Catfish <i>Pelteobagrus fulvidraco</i>
by: Guang-Hui Chen, et al.
Published: (2020-07-01)

Effects of miR-101-3p on goat granulosa cells in vitro and ovarian development in vivo via STC1
by: Xiaopeng An, et al.
Published: (2020-10-01)

Circ_0027599/PHDLA1 suppresses gastric cancer progression by sponging miR-101-3p.1
by: Liang Wang, et al.
Published: (2018-11-01)

Pathogenesis of miR-155 on nonmodifiable and modifiable risk factors in Alzheimer’s disease
by: Jia-jia Liu, et al.
Published: (2023-07-01)

The expression profiling of serum miR-92a, miR-134 and miR-375 in acute ischemic stroke
by: Aya Tarek Salman, et al.
Published: (2022-12-01)

LncRNA SNHG6 sponges miR-101 and induces tamoxifen resistance in breast cancer cells through induction of EMT
by: Mohammad Imran Khan, et al.
Published: (2022-09-01)

The Expression Patterns and Implications of <i>MALAT1</i>, <i>MANCR</i>, <i>PSMA3-AS1</i> and <i>miR-101</i> in Esophageal Adenocarcinoma
by: Athanasios Syllaios, et al.
Published: (2023-12-01)

Interactive role of miR‐29, miR‐93, miR‐205, and VEGF in salivary adenoid cystic carcinoma
by: Parisa Bayat, et al.
Published: (2023-02-01)

In-Vitro Evaluation of miR-101-5P Effect on Herpes Simplex Virus Replication
by: Ahmad Piroozmand, et al.
Published: (2018-11-01)

CEBPα/miR-101b-3p promotes meningoencephalitis in mice infected with Angiostrongylus cantonensis by promoting microglial pyroptosis
by: Xingda Zeng, et al.
Published: (2023-02-01)

Alzheimer’s Disease—Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran
by: Klaus Grossmann
Published: (2021-04-01)

Changes in miR-124-1, miR-212, miR-132, miR-134, and miR-155 Expression Patterns after 7,12-Dimethylbenz(a)anthracene Treatment in CBA/Ca Mice
by: Andras Tomesz, et al.
Published: (2022-03-01)

miR-185-5p / ATG101 axis alleviated intestinal barrier damage in intestinal ischemia reperfusion through autophagy
by: Wendong Chen, et al.
Published: (2023-07-01)

Potential Diagnostic and Prognostic Utility of miR-141, miR-181b1, and miR-23b in Breast Cancer
by: Mohamed Taha, et al.
Published: (2020-11-01)

miR-93, miR-373, and miR-17-5p Negatively Regulate the Expression of TBP2 in Lung Cancer
by: Ye Li, et al.
Published: (2020-04-01)

Expression relationship and significance of NEAT1 and miR-27a-3p in serum and cerebrospinal fluid of patients with Alzheimer’s disease
by: Lijie He, et al.
Published: (2022-06-01)

Amyloidosis in Alzheimer’s Disease: Pathogeny, Etiology, and Related Therapeutic Directions
by: Chen Ma, et al.
Published: (2022-02-01)

Krüppel-like factor 4 modulates the miR-101/COL10A1 axis to inhibit renal fibrosis after AKI by regulating epithelial–mesenchymal transition
by: Jingying Zhao, et al.
Published: (2024-12-01)

Evaluation of miR-143 and miR-145 Expression in Tumors and Tumor Margins in Patients with Colorectal Cancer
by: Shabnam Vardini, et al.
Published: (2017-12-01)

miR‐107‐5p ameliorates neurological damage, oxidative stress, and immune responses in mice with Alzheimer's disease by suppressing the Toll‐like receptor 4 (TLR4)/nuclear factor‐kappaB(NF‐κB) pathway
by: Guang‐Jun Hu, et al.
Published: (2024-02-01)

Circulating miR-206, miR-181b, and miR-21 as promising biomarkers in hypothyroidism and their relationship to related hyperlipidemia and hepatic steatosis
by: Asmaa Mohammed, et al.
Published: (2024-02-01)

LncRNA SPRY4‐IT1 facilitates cell proliferation and angiogenesis of glioma via the miR‐101‐3p/EZH2/VEGFA signaling axis
by: Ji Wang, et al.
Published: (2023-03-01)

RNA‐sequence‐based microRNA expression signature in breast cancer: tumor‐suppressive miR‐101‐5p regulates molecular pathogenesis
by: Hiroko Toda, et al.
Published: (2020-02-01)

Role of circulating miR 194-5p, miR 106b, and miR 146a as potential biomarkers for epilepsy: a case-control study
by: Mervat Moustafa, et al.
Published: (2020-07-01)

Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma
by: Khalda S. Amr, et al.
Published: (2017-12-01)

Preclinical Evaluation of miR-15/107 Family Members as Multifactorial Drug Targets for Alzheimer's Disease
by: Sepideh Parsi, et al.
Published: (2015-01-01)

MiR‐195 and miR‐497 suppress tumorigenesis in lung cancer by inhibiting SMURF2‐induced TGF‐β receptor I ubiquitination
by: Dong‐Kyu Chae, et al.
Published: (2019-12-01)

Novel harmine derivatives as potent acetylcholinesterase and amyloid beta aggregation dual inhibitors for management of Alzheimer’s disease
by: Hongtao Du, et al.
Published: (2023-12-01)

Evaluating the effects of curcumin nano-chitosan on miR-221 and miR-222 expression and Wnt/β-catenin pathways in MCF-7, MDA-MB-231 and SKBR3 cell lines
by: Touba Eslaminejad, et al.
Published: (2024-02-01)